There were 1,142 press releases posted in the last 24 hours and 468,007 in the last 365 days.

SOTIO to Present at the LifeSci Partners Summer Symposium

PRAGUE, Czech Republic, July 30, 2020 (GLOBE NEWSWIRE) -- SOTIO, a clinical stage immuno-oncology company owned by PPF Group, today announced that Radek Špíšek, chief executive officer of SOTIO, will be presenting a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners on August 4 and 5, 2020. Please click the following link to register:

Presentation Details:
Date:   August 5, 2020
Time:   10:00 a.m. EDT

Company contact:   Media contact:
Richard Kapsa   Kirsten Frazer, Ph.D.
Head of Communication   LifeSci Communications
T: (+420) 224 174 448   T: +1 646-863-0222
M: (+420) 603 280 971    


SOTIO is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO’s robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a platform to streamline personalized active immune cell therapies and a new generation of potent and stable antibody-drug conjugates (ADCs). SOTIO is a member of the PPF Group. For more information, please visit the company’s website at

SOTIO is a registered trademark of SOTIO a.s. in selected countries.

Primary Logo